LRTM2 Antikörper (AA 36-310) (HRP)
-
- Target Alle LRTM2 Antikörper anzeigen
- LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))
-
Bindungsspezifität
- AA 36-310
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LRTM2 Antikörper ist konjugiert mit HRP
-
Applikation
- ELISA
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Leucine-rich repeat and transmembrane domain-containing protein 2 protein (36-310AA)
- Isotyp
- IgG
- Top Product
- Discover our top product LRTM2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LRTM2 (Leucine-Rich Repeats and Transmembrane Domains 2 (LRTM2))
- Andere Bezeichnung
- LRTM2 (LRTM2 Produkte)
- Synonyme
- A230084J22 antikoerper, AI841794 antikoerper, leucine rich repeats and transmembrane domains 2 antikoerper, leucine-rich repeats and transmembrane domains 2 antikoerper, LRTM2 antikoerper, Lrtm2 antikoerper
- Hintergrund
-
Background: cytoplasm, protein kinase inhibitor activity, cytokine-mediated signaling pathway, negative regulation of JAK-STAT cascade, negative regulation of protein kinase activity.
Aliases: Leucine-rich repeat and transmembrane domain-containing protein 2 antibody, Leucine-rich repeats and transmembrane domains 2 antibody, Lrtm2 antibody, LRTM2_HUMAN antibody
- UniProt
- Q8N967
-